Wow - unexpected bad news! How great that you used that wonderful 18F-DCFPyL PET/CT scan at JH. That saved you a lot of unnecessary SEs of radiation.
I think your intuition is correct to forget about
radiation for now. And he doesn't need any more imaging - it won't make one bit of difference to his therapy. You have to treat this systemically. Given the number of mets, Taxotere is certainly a good bet. You might also consider the clinical trials that combine Taxotere with immunotherapy. This provides it when it is likely to be more effective, and some of the SEs tend to cancel each other out)
/clinicaltrials.gov/ct2/show/NCT02649855 (with Prostvac at NIH)
/clinicaltrials.gov/ct2/show/NCT02793765 (with Ipilimumab at MSKCC)
/clinicaltrials.gov/ct2/show/NCT02793765 (with Provenge at UT Houston)
He could get early use of Xofigo at this study in Indianapolis:
/clinicaltrials.gov/ct2/show/NCT02582749He could possibly get early use of Xtandi on this one:
/clinicaltrials.gov/ct2/show/NCT02677896Or, he could possibly get a very promising new hormonal therapy, apalutamide (ARN-509):
/clinicaltrials.gov/ct2/show/study/NCT02489318Lots of good choices!
- Allen